Amicus Therapeutics Inc. News
Amicus Therapeutics Stock Rises; Sells Unit Stake in SPAC Deal
Amicus is selling a stake in its gene-therapy unit to ARYA Sciences Acquisition IV, a special purpose acquisition company sponsored by Perceptive Advisors.
HubSpot, Twitter, Sonos: Latest Upgrades and Downgrades
TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Estee Lauder, Twitter and Uber.
Amicus Reports Disappointing Tests Results for Pompe Disease Drug
Amicus tanks as analysts downgrade it after the company reported disappointing test results for its Pompe disease drug.
Fear of Big Sellers: Cramer's 'Mad Money' Recap
Jim Cramer says investors need to consider the bear the motivation, and they need to consider the big sellers they'll have to outrun.
FedEx, Funko, Amicus Therapeutics: 'Mad Money' Lightning Round
Jim Cramer takes a look at FedEx, Funko, Amicus Therapeutics, Turning Point Brands, Sirius XM Radio, and more.
Las Vegas Strip May Lose a Major Sports Franchise
Sin City usually gets what it wants. That may not happen this time.
Steve Jobs Gets Posthumous Award From President Joe Biden
Jobs was one of 17 people to be awarded the Presidential Medal of Freedom.
Target Has a Surprising New Idea For Cereal Fans
This throwback will excite fans who fondly remember cereals from their childhoods.
TikTok Faces a New Major Threat
The popular short-form social media company is in the hot seat once again in the U.S.